1 Schmitt GJ, Meisenzahl EM, Frodl T, et al. Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by[(123)I]IBZM SPECT. Psychiatry Res, 2009, 173(3):183-189
2 Siever LJ, Davis KL. The pathophysiology of schizophrenia disorders:perspectives from the spectrum. Am J Psychiatry, 2004, 161(3):398-413
3 Biswal B, Yetkin FZ, Haughton VM, et al. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Neuron, 1997, 19(3):591-611
4 Breiter HC, Gollub RL, Weisskoff RM, et al. Acute effects of cocaine on human brain activity and emotion. J Neurosci, 2001, 21:RC159
5 Knutson B, Adams CM, Fong GW, et al. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. Magn Reson Med, 1995, 34(4):537-541
6 Chudasama Y, Robbins TW. Functions of frontostriatal systems in cognition:comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol, 2006, 73 (1):19-38
7 Graybiel AM. The basal ganglia:learning new tricks and loving it. Curr Opin Neurobiol, 2005, 15(6):638-644
8 Rogers RD, Andrews TC, Grasby PM, et al. Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J Cogn Neurosci, 2000, 12(1):142-162
9 Berridge KC, Robinson TE. What is the role of dopamine in reward:hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev, 1998, 28(3):309-369
10 Robbins TW, Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Curr Opin Neurobiol, 1996, 6(2):228-236
11 Wise RA. Neuroleptics and operant-behavior:the anhedoniahypothesis. Behavioral and brain sciences, 1982, 5:39-53
12 Akil M, Brewer GJ. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol, 1995, 65:171-178
13 Oder W, Grimm G, Kollegger H, et al. Neurological and neuropsychiatric spectrum of Wilson's disease:aprospective study of 45 cases. J Neurol, 1991, 238(5):281-287
14 Cedarbaum JM, Schleifer LS. Drugs for Parkinson's disease, spasticity, and acute muscle spasms. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 1990. 479-480
15 Kulik AV, Wilbur R. Delirium and stereotypy from anticholinergic antiparkinson drugs. Prog Neuropsychopharmacol Biol Psychiatry, 1982, 6(1):75-82
16 Carlsson A, Waters N, Carlsson ML. Neurotransmitter interactions in schizophrenia——therapeutic implications. Biol Psychiatry, 1999, 46(10):1388-1395
17 Sesack SR, Carr DB. Selective prefrontal cortex inputs to dopamine cells:implications for schizophrenia. Physiol Behav, 2002, 77(4-5):513-517
18 Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis:neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry, 2002, 159 (10):1642-1652
19 Sheline YI, Price JL, Yan Z. Resting-state functional MRI indepression unmasks increased connectivity between networks via the dorsalnexus. Proceedings of the National Academy of Sciences, 2010, 107(24):11020-11025
20 Fox MD, Greicius M. Clinical applications of resting state functional connectivity. Front Syst Neurosci, 2010, 4:19
21 Tzourio-Mazoyer N, Landeau B, Papathanassiou D. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI singlesubject brain. Neuroimage, 2002, 15(3):273-289
22 First MB, Spitzer, RL, Gibbon, M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P). New York(NY):Biometrics Research Department:New York State Psychiatric Institute, 1996
23 Annett M. A classification of hand preference by association analysis. Br J Psychol, 1970, 61(3):303-321
24 Andreasen NC. The Scale for the Assessment of Positive Symptoms in Schizophrenia. Iowa:The University of Iowa, 1984a
25 Andreasen NC. The Scale for the Assessment of Negative Symptoms in Schizophrenia. Iowa:The University of Iowa, 1984b
26 Andreasen NC. Scale for the Assessment of Negative Symptoms. Iowa City:University of Iowa, 1983
27 Lewdorowicz M, Yoffe Y, Zuberek J, et al. Chemical synthesis and binding activity of the trypanosomatid cap-4 structure. RNA, 2004, 10:1469-1478
28 Chepenik LG, Raffo M, Hampson M, et al. Functional connectivity between ventral prefrontal cortex and amygdala at low frequency in the resting state in bipolar disorder. Psychiatry Psychiatry Research-Neuroimaging, 2010, 182(3):207-210
29 Öngür D, Lundy M, Greenhouse I, et al. Default mode network abnormalities in bipolar disorder and schizophrenia. Psychiatry Research-Neuroimaging, 2010, 183(1):59-68
30 Weinberger DR, Radulescu E. Finding the Elusive Psychiatric "Lesion" With 21st-Century Neuroanatomy:A Note of Caution. Am J Psychiatry, 2016, 173:27-33
31 Howes OD, Kapur S. The dopamine hypothesis of schizophrenia:version Ⅲ——the final common pathway. Schizophr Bull, 2009, 35(3):549-562
32 Fusar-Poli P, Howes OD, Allen P, et al. Abnormal frontostriatal interactions in people with prodromal signs of psychosis:a multimodal imaging study. Arch Gen Psychiatry, 2010, 67(7):683-691
33 Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry, 2009, 66(1):13-20
34 Kegeles LS, Abi-Dargham A, Frankle WG, et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry, 2010, 67(3):231-239
35 Agid O, Mamo D, Ginovart N, et al. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response——a double-blind PET study in schizophrenia. Neuropsychopharmacology, 2007, 32(6):1209-1215
36 Dandash O, Fornito A, Lee J, et al. Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis. Schizophr Bull, 2014, 40(4):904-913
37 Teng S, Lu CF, Wang PS, et al. Altered resting-state functional connectivity of striatal-thalamic circuit in bipolar disorder. PLoS One, 2014, 9(5):e96422
38 Haznedar MM, Roversi F, Pallanti S, et al. Fronto-thalamostriatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Bipolar Disorders, 2009, 11(1):11-18
39 Sussmann JE, Lymer GKS, McKirdy J, et al. White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging. Biological Psychiatry, 2005, 57(7):733-742
40 Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 1988, 1(3):179-186
41 Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci, 1986, 9:357-381
42 Andreasen NC, O'Leary DS, Cizadlo T, et al. Schizophrenia and cognitive dysmetria:a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA, 1996, 93(18):9985-9990
43 Meyer-Lindenberg A, Miletich RS, Kohn PD, et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci, 2002, 5(3):267-271
44 Bernacer J, Prensa L, Gimenez-Amaya JM. Distribution of GABAergic interneurons and dopaminergic cells in the functional territories of the human striatum. PLoS One, 2012, 7 (1):e30504
45 Menon V, Anagnoson RT, Glover GH, et al. Functional magnetic resonance imaging evidence for disrupted basal ganglia function in schizophrenia. Am J Psychiatry, 2001, 158(4):646-649
46 Simpson EH, Kellendonk C, Kandel E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron, 2010, 65(5):585-596
47 Howes OD, Montgomery AJ, Asselin MC, et al. Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl, 2007, 51:s13-18
|